Diabetes is a leading cause of morbidity and death in the United States. Type 2 diabetes, the most common form, is associated with obesity and characterized by resistance to the actions of insulin. Although the underiying mechanisms are complex and controversial, it is now clear that type 2 diabetes is a chronic inflammatory state, and that inflammation modulates glucose metabolism. We were first to describe a novel secreted protein called resistin that exacerbates insulin resistance. In mice, resistin is adipocyte-specific and expressed constitutively, but human resistin is produced predominantly by macrophages and induced by nflammatory stimuli. Epidemiologic and genetic evidence supports a role for resistin in human diabetes and cardiovascular disease, and we have demonstrated that macrophage-derived human resistin is sufficient to exacerbate diet-induced insulin resistance. However, the metabolic effects of inflammation-induced resistin are not known. We now have established an innovative humanized resistin model in which mice lacking mouse resistin express low circulating levels of resistin that increase with high fat diet and after exposure to endotoxin.
Specific Aim 1 is to determine the impact of humanized resistin expression on obesity- and inflammation-associated insulin resistance. We hypothesize that humanized resistin expression induces insulin resistance that is chronically deleterious but protective hypoglycemia, and will evaluate this using innovative models of inflammation interrogated by glucose and insulin clamp studies.
Specific Aim 2 is to determine the effects of humanized resistin expression on cardiovascular disease. We hypothesize that the humanized expression of resistin will exacerbate heart failure, and will test this in appropriate models.
Specific Aim 3 is to detennine the mechanism of species- and cell-specificity of resistin expression, applying an innovative epigenomic discovery approach will to this important problem. Together, the proposed studies will address critical questions about the role of resistin as a link between inflammation, insulin resistance, and cardiometabolic diseases, and a potential target for intervention in these devastating diseases. These studies have important implications for our society in which metabolic diseases are rampant.

Public Health Relevance

Diabetes is a leading cause of morbidity and death in the United States. Type 2 diabetes, the most common form of diabetes, is associated with obesity and characterized by resistance to the actions of insulin. Understanding the mechanism of insulin resistance is critical to finding new therapies. We are determining the role of resistin, which exacerbates insulin resistance and is induced by inflammation in humans. Resistin may be a target for novel therapies that stem the tide of the epidemic of metabolic disease in our society.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Program Projects (P01)
Project #
5P01DK049210-18
Application #
8663224
Study Section
Special Emphasis Panel (ZDK1-GRB-9)
Project Start
Project End
Budget Start
2014-06-01
Budget End
2015-05-31
Support Year
18
Fiscal Year
2014
Total Cost
$319,139
Indirect Cost
$119,677
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Park, Hyeong-Kyu; Ahima, Rexford S (2015) Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism. Metabolism 64:24-34
Soleimanpour, Scott A; Gupta, Aditi; Bakay, Marina et al. (2014) The diabetes susceptibility gene Clec16a regulates mitophagy. Cell 157:1577-90
Jiang, Shaoning; Park, Dae Won; Tadie, Jean-Marc et al. (2014) Human resistin promotes neutrophil proinflammatory activation and neutrophil extracellular trap formation and increases severity of acute lung injury. J Immunol 192:4795-803
Lee, Dolim; Le Lay, John; Kaestner, Klaus H (2014) The transcription factor CREB has no non-redundant functions in hepatic glucose metabolism in mice. Diabetologia 57:1242-8
Lee, Sahmin; Lee, Hyun-Chae; Kwon, Yoo-Wook et al. (2014) Adenylyl cyclase-associated protein 1 is a receptor for human resistin and mediates inflammatory actions of human monocytes. Cell Metab 19:484-97
Baur, Joseph A; Birnbaum, Morris J (2014) Control of gluconeogenesis by metformin: does redox trump energy charge? Cell Metab 20:197-9
Shin, Soona; Kaestner, Klaus H (2014) The origin, biology, and therapeutic potential of facultative adult hepatic progenitor cells. Curr Top Dev Biol 107:269-92
Roat, Regan; Rao, Vandana; Doliba, Nicolai M et al. (2014) Alterations of pancreatic islet structure, metabolism and gene expression in diet-induced obese C57BL/6J mice. PLoS One 9:e86815
Liew, Chong Wee; Assmann, Anke; Templin, Andrew T et al. (2014) Insulin regulates carboxypeptidase E by modulating translation initiation scaffolding protein eIF4G1 in pancreatic ? cells. Proc Natl Acad Sci U S A 111:E2319-28
Carr, Rotonya M; Peralta, Giselle; Yin, Xiaoyan et al. (2014) Absence of perilipin 2 prevents hepatic steatosis, glucose intolerance and ceramide accumulation in alcohol-fed mice. PLoS One 9:e97118

Showing the most recent 10 out of 167 publications